Comparison of Five TSH-Receptor Antibody Assays in Graves' disease: results from an observational pilot study.

The assays tested had good diagnostic power and relapse risk prediction with few differences among the new assays. Due to the small sample size and retrospective design with possible selection bias, our data need prospective validation.